Ninety-eight fixed drug eruptions with provocation tests

Dermatology

Volumn 177, Issue 5, 1988, Pages 274-279

  Kanwar, A J ^a   Bharija, S C ^a   Singh, M ^a   Belhaj, M S ^a  

^a AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

Fixed drug eruption; Provocation test; Sulphamethoxazole; Trimethoprim

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ERYTHROMYCIN; IBUPROFEN; OXYPHENBUTAZONE; PARACETAMOL; PHENOBARBITAL; PHENOLPHTHALEIN; SCOPOLAMINE BUTYL BROMIDE; SULFADIAZINE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; CHILD; DRUG ERUPTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST;

ADOLESCENT; ADULT; AGED; CHILD; DRUG ERUPTIONS; DRUG THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGE; MUCOUS MEMBRANE; SKIN TESTS;

EID: 0023715258     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000248578     Document Type: Article

References (21)

1. Brocq L: Eruption erythemato-pigmentee fixe due a l’antipyrine. Ann Dermatol Venereol 1894; 5:308-313.
2. Korkij, W, Soltani K: Fixed drug eruption - a brief review. Arch Dermatol 1984;120:520-524.
3. Kaupinen K, Stubb S: Fixed eruptions - causative drugs and challenge tests. Br J Dermatol 1985; 112:575-578.
4. Moscher DB, Fitzpatrick TB, Ortonne JP: Abnormalities of pigmentation; in Fitzpatrick et al (eds): Dermatology in General Medicine, ed. 2. New York, McGraw'-Hill, 1979, p 568.
5. Kanw'ar AJ, Belhaj MS, Bharija SC, et al: Drugs causing fixed eruptions. J Dermatol (Tokyo) 1984; 11:383-386.
6. Kanwar AJ, Bharija SC, Belhaj MS: Fixed drug eruptions in children - a series of 23 cases with provocation tests. Dermatologica 1986;172: 315-319.
7. Kaupinen K: Rational performance of drug challenge in cutaneous hypersensitivity. Semin Dermatol 1983;2:227-238.
8. Hindscn M, Christensen OB, Gruic V, et al: Fixed drug eruption: An immunohistochemical investigation of the acute an healing phase. Br J Dermatol 1987;116:351-360.
9. Basset A, Payet M, et al: L’importance des facteurs raciaux dans l’erytheme pigmente fixe. Bull Soc Fr Dermatol Syph 1967;74:181-183.
10. Canizares O: Clinical Tropical Dermatology. Oxford, Blackwell, 1975.
11. Welsh AL: The fixed eruption. Springfield, Thomas, 1961.
12. Gardner P, Cluff LE: The epidemiology of adverse drug reactions - a review. John Hopkins Med J 1970;126:77-87.
13. Pasricha JS: Drugs causing fixed eruptions. Br J Dermatol 1979;100:183-185.
14. Gibson JR: Recurrent trimethoprim associated fixed skin eruption. Br Med J 1982;284:1529-1530.
15. Kanwar AJ, Bharija SC, Singh M, et al: Fixed drug eruption to trimethoprim. Dermatologica 1986; 172:230.
16. Verbov J: Fixed drug eruption due to a drug combination but not to its constituents. Dermatologica 1985;171:60-61.
17. Wintroub BU, Schiffmann NJ, Arndt KA: Adverse cutaneous reactions to drugs; in Fitzpatrick et al (eds): Dermatology in General Medicine, cd 2. New York, McGraw-Hill, 1979, p 561.
18. Nayyar KC, Pasricha JS: Fixed drug eruption to oxyphenbutazone and phenylbutazone. Dermatologica 1972;144:214-216.
19. Chargin L, Leifer W: Fixed eruptions due to ars-phenamines. J Invest Dermatol 1940;3:443-463.
20. Lever WF, Schaumburg-Lever G: Histopathology of Skin, ed 6. Philadelphia, Lippincott, 1983, p 259.
21. Savin JA: Current causes of fixed drug eruptions. Br J Dermatol 1970;83:546-549.